These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 347801)

  • 1. [Current possibilities in differential diagnosis of leukemias using surface alloantigens and complement receptors].
    Wernet P; Müller C; Barth P; Schunter F; Wilms K; Waller HD
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1813-5. PubMed ID: 347801
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of a combined rosette-fluorescent test in studies on leukemia cells.
    Stella-Hołowiecka B; Hołowiecki J; Szeruda-Rudzka E; Krawczyk-Kuliś M
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):165-70. PubMed ID: 375866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell markers in lymphomas and leukemias.
    Bowman WP; Melvin S; Mauer AM
    Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847
    [No Abstract]   [Full Text] [Related]  

  • 4. New aspects in the classification of leukemic cell types by Ia alloantigens and complement receptors.
    Wernet P; Schunter F; Wilms K; Waller HD
    Haematol Blood Transfus; 1977; 20():333-9. PubMed ID: 305401
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic diagnosis of variants of chronic lymphoid leukemia and lymphosarcomas].
    Samoĭlova RS; Ol'shevskaia EV; Polianskaia AM
    Ter Arkh; 1981; 53(11):73-8. PubMed ID: 7041315
    [No Abstract]   [Full Text] [Related]  

  • 6. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
    Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
    Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic basis for the redefinition of malignant lymphomas.
    Parker JW
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):670-86. PubMed ID: 386778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human lymphatic leukemias: T and B cell proliferations.
    Zipori D; Shani A; Burstein R; Cohen A; Haimovich Y; Efrati P; Bentwich Z
    Isr J Med Sci; 1977 Aug; 13(8):753-7. PubMed ID: 408294
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phenotype characterization of chronic lymphatic leukemia with monoclonal antibodies and membrane receptors].
    Estevez ME; Sen L; Diez RA; Bellouard A; Santos I
    Medicina (B Aires); 1981; 41 Suppl():123-30. PubMed ID: 7047978
    [No Abstract]   [Full Text] [Related]  

  • 10. Identifying and enumerating human T and B lymphocytes. A review of techniques, problems, and progress in clinical studies.
    Dwyer JM
    Prog Allergy; 1976; 21():178-260. PubMed ID: 794886
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte receptors. I. Receptors for Fc of IgG and complement (C3b) on immunoglobulin-bearing, antigen-binding and antibody-secreting cells.
    McConnell I; Hurd CM
    Immunology; 1976 Jun; 30(6):825-33. PubMed ID: 800392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases.
    Lukes RJ; Parker JW; Taylor CR; Tindle BH; Cramer AD; Lincoln TL
    Semin Hematol; 1978 Oct; 15(4):322-51. PubMed ID: 366759
    [No Abstract]   [Full Text] [Related]  

  • 13. Human peripheral lymphocytes bearing surface immunoglobulin do not have readily detectable Fc receptors.
    Alexander EL; Henkart PA
    Clin Exp Immunol; 1978 Aug; 33(2):332-9. PubMed ID: 363317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute leukemia in childhood: comparison of immunological histochemical and clinical findings.
    Winterleitner H; Krepler P; Knapp W
    Padiatr Padol; 1980; 15(3):221-32. PubMed ID: 6968053
    [No Abstract]   [Full Text] [Related]  

  • 15. Immuno-methods in diagnostic hematopathology.
    Taylor CR; Parker JW
    Methods Achiev Exp Pathol; 1981; 10():37-72. PubMed ID: 7047989
    [No Abstract]   [Full Text] [Related]  

  • 16. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B- and T-lymphocyte markers on transformed lymphocytes from mitogen-stimulated cultures of normal and CLL lymphocytes and on tonsil blasts.
    Smith JL; Haegert D
    Clin Exp Immunol; 1974 Aug; 17(4):547-60. PubMed ID: 4549576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia.
    Aisenberg AC; Wilkes BM
    Cancer Res; 1981 Nov; 41(11 Pt 2):4810-3. PubMed ID: 6975164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
    Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF
    Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ
    Curr Top Hematol; 1980; 3():175-240. PubMed ID: 6276102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.